Genetic Penetrance of Macular Telangiectasia Type 2

被引:17
|
作者
Ronquillo, Cecinio C. [1 ]
Wegner, Kimberley [1 ]
Calvo, Charles M. [1 ]
Bernstein, Paul S. [1 ]
机构
[1] Univ Utah, Dept Ophthalmol & Visual Sci, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1001/jamaophthalmol.2018.3283
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
IMPORTANCE The apparent genetic penetrance of macular telangiectasia type 2 (MacTel) is important for gene discovery studies and for clinical risk assessment of affected individuals' family members. OBJECTIVE To determine the genetic penetrance of MacTel. DESIGN, SETTING. AND PARTICIPANTS Descriptive cross sectional study of patients with MacTel at a tertiary referral eye center. From 2008 to 2016, consecutive patients with MacTel were independently identified, and all of their available siblings and parents were recruited. Seventeen probands with MacTel were included in the study who satisfied the requirement of having at least 1 parent or sibling willing and able to participate. Data from these 17 families were included for the analysis of apparent genetic penetrance. MAIN OUTCOMES AND MEASURES Determination of MacTel genetic penetrance in probands' parents and siblings. RESULTS Of 80 study participants, 50 (62.5%) were women. The mean (SD) age of study participants with MacTel was 61.2 (14.0) years (range, 23-81years) and without MacTel was 60.7 (16.4) years (range, 24-92 years). There were 17 MacTel probands, and there was a high rate of enrollment of living siblings and parents: 52 of 71 living siblings (73%) and 11 of 12 parents (92%). Of 52 enrolled siblings. 9 (17%) were affected. Of 11 enrolled parents, 3 (27%) had MacTel. Apparent genetic penetrance was calculated to be 0.35 (95% CI, 0.14-0.6) by sibling analysis and 0.55 (95% CI, 0.02-1.00) by parent analysis. Combining the sibling and parent analyses, the apparent penetrance was calculated to be 0.38 (95% CI, 0.19-0.57). CONCLUSIONS AND RELEVANCE The genetic penetrance of MacTel in rigorously phenotyped multiple large families is described. Families such as these could be critical for successful identification of MacTel genes.
引用
收藏
页码:1158 / 1163
页数:6
相关论文
共 50 条
  • [31] Multifocal electroretinography in type 2 idiopathic macular telangiectasia
    Narayanan, Raja
    Dave, Vivek
    Rani, Padmaja K.
    Chhablani, Jay
    Rao, Harsha B.
    Pappuru, Rajeev R.
    Jalali, Subhadra
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (05) : 1311 - 1318
  • [32] Progressive Neurodegeneration in Macular Telangiectasia Type 2 (MacTel)
    Amram, Alec Lee
    Whitmore, S. Scott
    Clavell, Christine
    Lyons, Lance
    Rusakevich, Alexander Michael
    Han, Ian
    Folk, James C.
    Boldt, H. Culver
    Gehrs, Karen
    Stone, Edwin M.
    Russell, Stephen R.
    Lee, Kyungmoo
    Abramoff, Michael David
    Wykoff, Charles Clifton
    Sohn, Elliott H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [33] Retinal Crystals in Type 2 Idiopathic Macular Telangiectasia
    Sallo, F. B.
    Leung, I.
    Wolf-Schnurrbusch, U. E.
    Bird, A. C.
    Peto, T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [34] OCT Angiography (OCTA) of Macular Telangiectasia Type 2
    Legarreta, John Edward
    Legarreta, Andrew Dominic
    Thorell, Mariana R.
    Zhang, Qinqin
    Gregori, Giovanni
    Matsunaga, Douglas
    Kashani, Amir H.
    Wang, Ruikang K.
    Puliafito, Carmen A.
    Rosenfeld, Philip J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [35] Unusual Presentations of Type 2 Idiopathic Macular Telangiectasia
    Atmani, K.
    Querques, G.
    Zourdani, A.
    Benhamou, N.
    Souied, E. H.
    OPHTHALMOLOGICA, 2013, 230 (03) : 126 - 130
  • [36] Analysis of candidate genes for macular telangiectasia type 2
    Parmalee, Nancy L.
    Schubert, Carl
    Merriam, Joanna E.
    Allikmets, Kaija
    Bird, Alan C.
    Gillies, Mark C.
    Peto, Tunde
    Figueroa, Maria
    Friedlander, Martin
    Fruttiger, Marcus
    Greenwood, John
    Moss, Stephen E.
    Smith, Lois E. H.
    Toomes, Carmel
    Inglehearn, Chris F.
    Allikmets, Rando
    MOLECULAR VISION, 2010, 16 (289-90): : 2718 - 2726
  • [37] Binocular Inhibition of Reading in Macular Telangiectasia Type 2
    Tzaridis, Simone
    Herrmann, Philipp
    Issa, Peter Charbel
    Degli Esposti, Simona
    Wagner, Siegfried K.
    Fruttiger, Marcus
    Egan, Catherine
    Rubin, Gary
    Holz, Frank G.
    Heeren, Tjebo F. C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (12) : 3835 - 3841
  • [38] THE IMPACT OF DIABETES ON THE CHARACTERISTICS OF TYPE 2 MACULAR TELANGIECTASIA
    Peto, T.
    Clemons, T. E.
    Sallo, F. B.
    Leung, I.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2011, 21 (03) : 347 - 347
  • [39] Intravitreous Ranibizumab as Treatment for Macular Telangiectasia Type 2
    Cavalcanti Lira, Rodrigo Pessoa
    Silva, Valdir Balarin
    Cavalcanti, Tiago Marques
    Delgado de Souza, Ana Catarina
    da Costa Pinto, Alexandre Paashaus
    ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (08) : 1075 - 1078
  • [40] Multifocal electroretinography in patients with macular telangiectasia type 2
    Neha Goel
    Anjula Kumari
    Satish Kumar
    Aanchal Mehta
    Documenta Ophthalmologica, 2020, 141 : 15 - 21